Antiprotozoa for intramuscular injection which offers a safe and convenient alternative to existing antitheilerial products.
| Active Ingredients | |
|---|---|
| Buparvaquone | 50 mg/ml |
| Parasites, Vectors & Organisms Controlled | |
| Theileria parva | ✓ |
| Theileria annulata | ✓ |
| Theileria mutans | ✓ |
| Theileria orientalis | ✓ |
For the treatment of theileriosis (East Coast Fever, January Disease, Corridor disease, Tropical theileriosis etc) in cattle caused by Theileria parva, T. annulata, T. mutans, and T. orientalis.
Active against both the schizonts and piroplasms stages of Theileria and may be used during the incubation period of the disease or when clinical signs are apparent.
Butalex should never be given by intravenous or subcutaneous injection.
Application Rate
For intramuscular injection into the neck muscles.
Dose rates/directions for use:
A single dose of 1ml per 20kg bodyweight. (2.5mg buparvaquone/ kg bodyweight).
In severe and advanced cases, a second treatment may be required at 48-72 hrs after the initial injection at the same dose rate.
Avoid wet or dirty areas of the skin.
No more than 10ml should be injected into a single site.
